Carl DeSelm, M.D., Ph.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carl DeSelm, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04331041 · Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas AdenocarcinomaWashington University School of Medicine · active not recruiting · Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor ImmunityR01CA248917 · NCI · WASHINGTON UNIVERSITY · PI David G DeNardo, HYUN KIM, Julie Kristina Schwarz · fiscal years 2020 to 2024Named on NCT04331041
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.